Asia/Oceania

In Brief This Week: Legend Biotech, Point Biopharma, AstraZeneca, Daiichi Sankyo, Takeda, Micronoma

Bio4t2 Begins Dosing Solid Tumor Patients in First-In-Human CAR T-Cell Therapy Trial

Prenetics' ACT Genomics Profiling Test for Solid Tumors Receives FDA Clearance

METiS Inks Exclusive Licensing Agreement With Evopoint Biosciences for SOS1 Inhibitor

China's NMPA Accepts New Drug Application for Legend Biotech, Janssen's Carvykti

Esophageal Cancer Molecular Study Highlights Tumor Subtypes, Treatment Response Markers

Mission Bio, Abiosciences to Develop Analytics For Studying Hematologic Cancers

Anuva, Max Healthcare Conducting Genomics Research to Advance Precision Medicine

FDA Clears Iaso Biotherapeutics for US Trials of BCMA-Targeted CAR-T Therapy in Multiple Myeloma

Merck Pays $175M Upfront for Rights to Seven Kelun-Biotech Antibody-Drug Conjugate Candidates

Japanese Lung Cancer Genomic Screening Project Expands in Asia-Pacific

SeekIn Receives CE-IVD Mark for Leukemia Cancer Mutation Detection Kit

Prenetics to Take Majority Stake in ACT Genomics

Daiichi Sankyo Transfers Rights to Market Yescarta in Japan to Gilead Sciences

Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement

Akeso, Summit Therapeutics Ink $5B Licensing Deal for PD-1/VEGF Bispecific Antibody

Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer

ICPO Foundation, PreMIT Collaborate to Establish Theranostic Centers

SeekIn Receives CE-IVD Mark for Cancer Recurrence Monitoring Test

Clarity Pharmaceuticals to Evaluate GRPr-Targeting Radiopharmaceutical in mCRPC Trial